HELPLINE
In this episode of Meso TV, our Director of Patient Services, Julie, talks with Dr. Timothy Yap from MD Anderson Cancer Center about the VT3989 clinical trial for mesothelioma. He explains what this new treatment is, how it works, and what it could mean for patients.VT3989 is a YAP/TEAD inhibitor,…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, Pennsylvania. This panel is moderated by patient Jessica Blackford-Cleeton and includes mesothelioma patients who have been on or are currently on clinical trials.This panel discussion features mesothelioma patients who are currently participating in,…
Our Patient Services Director, Julie White, RN, BSN, OCN, sits down with Aaron Mansfield, MD. Dr. Mansfield is a medical oncologist and researcher at the Mayo Clinic in Rochester, Minnesota. He discusses multimodality clinical trials with Julie. Our SponsorsMesoTV is a program by the Mesothelioma Applied Research Foundation. This program is…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, Pennsylvania. Dean Fennell, FRCP, PhD, from University of Leicester presents on what is new in clinical trials.This presentation provides an up-to-date overview of the latest developments in clinical trials for mesothelioma, offering patients…
Our Patient Services Director, Julie White, RN, BSN, OCN, sits down with Michael Offin, MD to discuss a clinical trial . Dr. Offin is a Thoracic Medical Oncologist at Memorial Sloan Kettering Cancer Center. They discuss a current clinical trial for mesothelioma. Our Sponsors MesoTV is a program by the Mesothelioma…
On this episode of MesoTV, join our Patient Services Director, Julie White, as she speaks with Marjorie Zauderer, MD, MS, FACP, and Lee Krug, MD, about the eVOLVE meso clinical trial for patients with pleural mesothelioma. Our SponsorsMesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made…
A phase 3 randomized clinical trial looking into the efficacy of combination chemotherapy with immunotherapy is now open in the United States and Australia. How…
Marjorie G. Zauderer, MD, discusses a currently enrolling Phase 1 clinical trial for mesothelioma patients. This CAR-T cell therapy trial targets mesothelin, a protein heavily…
In this video, Aaron Mansfield, MD, discusses a mesothelioma clinical trial currently available across the United States and in Canada using Keytruda (pembrolizumab) with or…
